By Category

Equipment and facility Findings

in this category 2,881 findings drawn from 1,938 published documents. The most recent cases are below; the full set is in search.

See all Equipment and facility findings

Which agency cited it

Health Canada 1,463
US FDA 1,418

Companies with the most findings

Recent findings

US FDA Corixa Corporation d.b.a. GlaxoSmithKline 2026-10-19

Inspection ofthe packaging facilities are deficient after use to assure that materials not suitable for subsequent operations have been removed.

View the regulator's official source

Narrow by agency

Other categories

These findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Counts are measured from public data as of 2026-10-20, and findings are extracted automatically from the regulator's published documents. “View official source” on each case links directly to that document.

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.